As of Jan 13
| -0.15 / -3.80%|
The 1 analysts offering 12-month price forecasts for KaloBios Pharmaceuticals Inc have a median target of 64.00, with a high estimate of 64.00 and a low estimate of 64.00. The median estimate represents a +1,584.21% increase from the last price of 3.80.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.